WILMINGTON, Del., June 4, 2018 /PRNewswire/ -- The Chemours
Company (Chemours) (NYSE: CC), a global chemistry company with
leading market positions in titanium technologies, fluoroproducts
and chemical solutions, today announced a 10 percent price increase
for all Methylamines, Dimethylformamide (DMF), Dimethylacetamide
(DMAc) and Dimethyl Sulfate (DMS) products sold in North
America. The price increase is effective July 1, 2018 or as contracts allow.
About The Chemours Company
The Chemours Company
(NYSE: CC) helps create a colorful, capable and cleaner world
through the power of chemistry. Chemours is a global leader
in titanium technologies, fluoroproducts and chemical solutions,
providing its customers with solutions in a wide range of
industries with market-defining products, application expertise and
chemistry-based innovations. Chemours ingredients are found
in plastics and coatings, refrigeration and air conditioning,
mining and general industrial manufacturing. Our flagship
products include prominent brands such as Teflon™, Ti-Pure™,
Krytox™, Viton™, Opteon™, Freon™ and Nafion™. Chemours has
approximately 7,000 employees and 26 manufacturing sites serving
approximately 4,000 customers in North
America, Latin America,
Asia-Pacific and Europe.
Chemours is headquartered in Wilmington,
Delaware and is listed on the NYSE under the symbol
CC. For more information please visit
chemours.com.
Forward Looking Statements
This press release contains
forward-looking statements, within the meaning of the safe harbor
provisions of the U.S. Private Securities Litigation Reform Act of
1995, that involve risks and uncertainties. Forward-looking
statements provide current expectations of future events based on
certain assumptions and include any statement that does not
directly relate to any historical or current fact. The words
"believe," "expect," "will," "anticipate," "plan," "estimate,"
"anticipate," "target," "project," and similar expressions, among
others, generally identify "forward-looking statements" which speak
only as of the date the statements were made. These forward-looking
statements may address, among other things, the outcome or
resolution of any pending or future environmental liabilities,
litigation and other legal proceedings or contingencies,
anticipated future operating and financial performance, business
plans and prospects, transformation plans, cost savings targets and
plans to increase profitability, that are subject to substantial
risks and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statements.
Forward-looking statements are based on certain assumptions and
expectations of future events which may not be accurate or
realized. Forward-looking statements also involve risks and
uncertainties which are beyond Chemours' control. Additionally,
there may be other risks and uncertainties that Chemours is unable
to identify at this time or that Chemours does not currently expect
to have a material impact on its business. Factors that could cause
or contribute to these differences include the risks, uncertainties
and other factors discussed in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K for
the year ended December 31, 2017.
Chemours assumes no obligation to revise or update any
forward-looking statement for any reason, except as required by
law.
CONTACTs:
NEWS MEDIA
Ted
Sikorski
Global Communications Leader, Chemical
Solutions & Titanium
Technologies
+1.302.773.2768
Ted.sikorski@chemours.com
INVESTORS
Jonathan
Lock
VP, Corporate Development and Investor
Relations
+1.302.773.2263
investor@chemours.com
View original
content:http://www.prnewswire.com/news-releases/chemours-announces-price-increase-for-methylamines-products-in-north-america-300659289.html
SOURCE The Chemours Company